The aMAP score involved age, sex, albumin-bilirubin and platelets, and satisfactorily predicted the risk of HCC development among over 17,000 patients with viral and non-viral hepatitis from 11 global prospective studies [64, 65]. The gene discussed is ALB; the disease is viral hepatitis.